Applications of Artificial Intelligence in Drug Repurposing
Zhaoman Wan,
No information about this author
Xinran Sun,
No information about this author
Yi Li
No information about this author
et al.
Advanced Science,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 6, 2025
Drug
repurposing
identifies
new
therapeutic
uses
for
the
existing
drugs
originally
developed
different
indications,
aiming
at
capitalizing
on
established
safety
and
efficacy
profiles
of
known
drugs.
Thus,
it
is
beneficial
to
bypass
early
stages
drug
development,
reduction
time
cost
associated
with
bringing
therapies
market.
Traditional
experimental
methods
are
often
time-consuming
expensive,
making
artificial
intelligence
(AI)
a
promising
alternative
due
its
lower
cost,
computational
advantages,
ability
uncover
hidden
patterns.
This
review
focuses
availability
AI
algorithms
in
their
positive
specific
roles
revealing
drugs,
especially
being
integrated
virtual
screening.
It
shown
that
excel
analyzing
large-scale
datasets,
identifying
complicated
patterns
responses
from
these
predictions
potential
repurposing.
Building
insights,
challenges
remain
developing
efficient
future
research,
including
integrating
drug-related
data
across
databases
better
repurposing,
enhancing
efficiency,
advancing
personalized
medicine.
Language: Английский
Decellularized Liver Matrices for Expanding the Donor Pool—An Evaluation of Existing Protocols and Future Trends
Biomolecules,
Journal Year:
2025,
Volume and Issue:
15(1), P. 98 - 98
Published: Jan. 10, 2025
Liver
transplantation
is
the
only
curative
option
for
end-stage
liver
disease
and
necessary
an
increasing
number
of
patients
with
advanced
primary
or
secondary
cancer.
Many
patient
groups
can
benefit
from
this
treatment,
however
shortage
grafts
remains
unsolved
problem.
bioengineering
offers
a
promising
method
expanding
donor
pool
through
production
acellular
scaffolds
that
be
seeded
recipient
cells.
Decellularization
protocols
involve
removal
cells
using
various
chemical,
physical,
enzymatic
steps
to
create
collagenous
network
provides
support
introduced
future
vascular
biliary
beds.
However,
causes
varying
degrees
matrix
damage,
affect
cell
seeding
organ
performance.
The
main
objective
review
present
existing
techniques
producing
decellularized
livers,
emphasis
on
assessment
definition
acellularity.
agents
are
discussed,
standard
process
evaluated.
We
also
introduce
concept
stepwise
during
decellularization
cycles.
This
may
lead
shorter
detergent
exposure
times
less
scaffold
damage.
introduction
apoptosis
induction
in
field
engineering
provide
valuable
alternative
long
perfusion
protocols,
which
significant
A
thorough
understanding
action
factors
influencing
final
composition
essential
produce
biocompatible
matrix,
basis
further
studies
regarding
recellularization
retransplantation.
Language: Английский
Conjugation of PDLA onto MgO Microspheres: Comparison between Solution Grafting and Melt Grafting Methods
Journal of Materials Chemistry B,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 1, 2025
MgO
microspheres
modified
by
solution
and
melt
grafting
methods
were
used
to
assess
the
effect
of
reaction
temperature
on
PDLA
graft
ratio,
resulting
in
varied
surface
morphologies
controllable
degradability
when
analyzed
kinetic
modeling.
Language: Английский
The P2X7-Mediated Mitochondrial ROS as an Emerging Core Target of Tuftsin Nanoparticles in Severe Acute Pancreatitis Therapy via Regulating Mitophagy
E Wen,
No information about this author
Yu Tian,
No information about this author
Mingxiao Fang
No information about this author
et al.
ACS Applied Materials & Interfaces,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 24, 2025
20%
acute
pancreatitis
(AP)
develops
into
severe
AP
(SAP),
a
global
health
crisis,
with
an
increased
mortality
rate
to
30%–50%.
Mitochondrial
damage
and
immune
disorders
are
direct
factors,
which
exacerbate
the
occurrence
progression
of
AP.
So
far,
mitochondrial
immunity
injury
in
SAP
remains
largely
elusive,
no
established
treatment
options
available.
Immunomodulation
is
promising
approach
treat
pancreatitis.
Herein,
we
proved
that
Tuftsin
(TN),
vital
endogenous
immunomodulator,
can
inhibit
SAP,
while
it
limited
by
extremely
short
biological
half-life,
low
bioavailability,
inconvenience
administration.
Nano
platform
positive
choice.
Interestingly,
found
activated
P2X7
signaling
was
closely
associated
enhanced
pancreatic
inflammation
via
damaging
function
SAP.
engineered
nanoplatform
containing
Se–Se
bond
responsive
for
ROS
deliver
TN,
namely,
DSPE–Se-Se-MPEG@TN
(DSSM@TN),
contributing
increases
TN's
half-life
bioavailability.
We
synthesized
TN-loaded
ROS-responsive
DSPE–Se-Se-
MPEG@TN
liposomes
(DSSM@TN
NPs)
one-step
emulsification
method,
exhibited
good
biosecurity,
high
stability,
suitable
size,
favorable
responsiveness
biocompatibility,
as
well
excellent
capability
releasing
TN
during
oxidative
stress
environment.
Moreover,
ability
first
play
role
enhance
its
anti-inflammation
antioxidant
abilities
targeting
damaged
mitochondria
progression.
Mechanistically,
DSSM@TN
pancreas
simultaneously
inhibits
dysfunction
vivo
vitro
signaling-impaired
Nrf2/HO-1
signaling-inhibited
PINK1/PARKIN
pathway.
Consequently,
such
immunotherapy
nanomedicine
targeted
holds
great
potential
facilitating
substantial
clinical
progress
treatment.
Language: Английский
Liver organoids: Current advances and future applications for hepatology
Clinical and Molecular Hepatology,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 26, 2024
The
creation
of
self-organizing
liver
organoids
represents
a
significant,
although
modest,
step
toward
addressing
the
ongoing
organ
shortage
crisis
in
allogeneic
transplantation.However,
researchers
have
recognized
that
achieving
fully
functional
whole
remains
distant
goal,
and
original
ambition
organoid-based
generation
has
been
temporarily
put
on
hold.Instead,
revolutionized
field
hepatology,
extending
their
influence
into
various
domains
precision
molecular
medicine.These
3D
cultures,
capable
replicating
key
features
human
function
pathology,
opened
new
avenues
for
human-relevant
disease
modeling,
CRISPR
gene
editing,
high-throughput
drug
screening
animal
models
cannot
accomplish.Moreover,
advancements
creating
more
complex
systems
led
to
development
multicellular
assembloids,
dynamic
organoid-on-chip
systems,
bioprinting
technologies.These
innovations
enable
detailed
modeling
microenvironments
tissue
interactions.Progress
regenerative
medicine
transplantation
applications
continues
evolve
strives
overcome
obstacles
biocompatibility
tumorigenecity.In
this
review,
we
examine
current
state
organoid
research
by
offering
insights
where
currently
stands,
pivotal
developments
are
driving
its
shaping
future.and
difficulties
screening,
which
is
one
advantages
2D
cell
culture
15
.Given
limitations
models,
such
as
organoids,
spheroids,
bioprinting,
recently
emerged
promising
technologies
address
these
challenges.Spheroids
represent
simplest
form
culture,
allowing
formation
spherical
structures
through
aggregation
without
need
extracellular
matrix
(ECM)
components
Matrigel
16-
20
.Their
simplicity
enables
easy
culturing,
they
widely
studied
types
aggregate
well,
cancer
cells,
embryoid
bodies,
hepatocytes.However,
most
spheroids
solid
structures,
limits
ability
replicate
specific
structural
characteristics
organs.Additionally,
delivery
nutrients
oxygen
cells
at
center
spheroid
challenging,
often
resulting
necrosis
other
17,20,21
.In
manuscript,
aim
focus
systems.In
2008,
when
self-organized
apico-basally
polarized
cortical
were
reported
from
embryonic
stem
(ESCs)
22
,
Lgr5-positive
isolated
adult
intestinal
shown
cryptvillus
structure
self-organization
23
studies
expansion
methods
published.Organoids
formed
(ASCs),
pluripotent
(PSCs)
or
progenitor
recapitulate
target
functions
24
.Organoids
actively
utilized
across
fields
because
incorporate
traditional
experimental
genetic
manipulation,
replication
physiological
25
.ASC-derived
isolating
primary
tissues
culturing
them
under
signaling
conditions
respective
organ,
maintain
structural,
physiological,
23,[26][27][28]
.These
ASC-organoid
stability
even
after
long-term
26
and,
can
be
generated
patient-derived
hold
potential
personalized
medicine,
toxicity
assessments
therapy.However,
requirement
invasive
procedures
obtain
patient
considered
drawback.On
hand,
PSC-derived
using
relatively
less
offer
advantage
generating
organs,
brain,
samples
difficult
[29][30][31][32]
.Brain
predominantly
conducted
induced-pluripotent
(iPSC)-derived
particularly
patient-specific
organoids.However,
differentiation
processes
required
generate
major
source
high
variability
among
33,34
.Additionally,
differences
between
PSC
lines
another
concern.Despite
challenges,
both
ASC-derived
effectively
vivo
organs
vitro
applications.By
leveraging
strengths
each
source,
effective
tailored
conducted.
Language: Английский